Artificial intelligence in healthcare: global implementation, legal regulation, problems and ethical issues
https://doi.org/10.17749/2070-4909/farmakoekonomika.2025.328
Abstract
Objective: To analyze the legal and ethical aspects of regulating artificial intelligence (AI) in medicine in key jurisdictions (United States, European Union, China, Russia), to identify regulatory gaps, ethical dilemmas and prospects for harmonization of standards.
Material and methods. National and international regulatory documents (GDPR, AI Act, FDA, NMPA), scientific publications, clinical cases and regulatory initiatives (IMDRF, WHO) were reviewed. Methods for comparative legal analysis and systematization of ethical and legal norms were used.
Results. Considerable differences in approaches to AI regulation were identified, including flexibility in the US, the ethical centricity in the EU, centralization in China and an emerging framework in Russia. Key issues were emphasized, such as algorithmic bias, AI transparency, responsibility, and the conflict between innovation and security.
Conclusion. The harmonization of international standards, the introduction of dynamic regulation and the strengthening of interdisciplinary cooperation should be pursued to achieve a balance between innovation and the protection of patients' rights.
About the Authors
D. I. Korabelnikov
Moscow Haass Medical and Social Institute
Russian Federation
Russian Federation
5 2nd Brestskaya Str., Moscow 123056
A. I. Lamotkin
Moscow Haass Medical and Social Institute; Central Research Institute of Organization and Informatization of Healthcare
Russian Federation
Russian Federation
5 2nd Brestskaya Str., Moscow 123056;
11 Dobrolyubov Str., Moscow 127254
References
1. Schulz W.L, Durant T.J.S, Krumholz H.M. Validation and regulation of clinical artificial intelligence. Clin Chem. 2019; 65 (10): 1336–7. https://doi.org/10.1373/clinchem.2019.308304.
2. Drabiak K., Kyzer S., Nemov V., El Naqa I. AI and machine learning ethics, law, diversity, and global impact. Br J Radiol. 2023; 96 (1150): 20220934. https://doi.org/10.1259/bjr.20220934.
3. World Health Organization. Ethics and governance of artificial intelligence for health: guidance on large multi-modal models. Available at: https://www.who.int/publications/i/item/9789240084759 (accessed 21.06.2025).
4. UNESCO. Recommendation on the ethics of artificial intelligence. Available at: https://www.unesco.org/en/articles/recommendation-ethics-artificial-intelligence (accessed 21.06.2025).
5. Regulation (EU) 2016/679 of the European Parliament and of the Council of 27 April 2016. Available at: https://eur-lex.europa.eu/legal-content/EN/TXT/PDF/?uri=CELEX:32016R0679 (accessed 21.06.2025).
6. IMDRF (International Medical Device Regulators Forum). Software as a medical device (SaMD): key definitions. Available at: https://www.imdrf.org/sites/default/files/2022-08/IMDRF%20SaMD%20WG%20N67FINAL2022.pdf (accessed 21.06.2025).
7. World Health Organization. Global Strategy on Digital Health 2020–2025. Available at: https://www.who.int/publications/i/item/9789240020924 (accessed 21.06.2025).
8. FDA draft guidance: marketing submission recommendations for a predetermined change control plan for artificial intelligence/machine learning (AI/ML)-enabled device software functions. Available at: https://www.fda.gov/media/166704/download (accessed 21.06.2025).
9. Hoffman R.R., Mueller S.T., Klein G., Litman J. Measures for explainable AI: Explanation goodness, user satisfaction, mental models, curiosity, trust, and human-AI performance. Front Comput Sci. 2023; 5. https://doi.org/10.3389/fcomp.2023.1096257.
10. Regulation (EU) 2024/1689 of the European Parliament and of the Council of 13 June 2024 laying down harmonised rules on artificial intelligence and amending Regulations (EC) No 300/2008, (EU) No 167/2013, (EU) No 168/2013, (EU) 2018/858, (EU) 2018/1139 and (EU) 2019/2144 and Directives 2014/90/EU, (EU) 2016/797 and (EU) 2020/1828 (Artificial Intelligence Act) (Text with EEA relevance). Available at: https://eur-lex.europa.eu/eli/reg/2024/1689/oj/eng (accessed 21.06.2025).
11. Duffourc M.N., Gerke S. Health care AI and patient privacy – Dinerstein v Google. JAMA. 2024; 331 (11): 909–10. https://doi.org/10.1001/jama.2024.1110.
12. Wong A., Otles E., Donnelly J.P., et al. External validation of a widely implemented proprietary sepsis prediction model in hospitalized patients. JAMA Intern Med. 2021; 181 (8): 1065–70. https://doi.org/10.1001/jamainternmed.2021.2626.
13. Wang C., Zhang J., Lassi N., Zhang X. Privacy protection in using artificial intelligence for healthcare: chinese regulation in comparative perspective. Healthcare. 2022; 10 (10): 1878. https://doi.org/10.3390/healthcare10101878.
14. Decree of the President of the RF dated 10.10.2019 No. 490 “On the development of artificial intelligence in the Russian Federation”. Available at: https://base.garant.ru/72838946/?ysclid=mcujb5g0yf582538441 (in Russ.) (accessed 23.06.2023).
15. Federal Law dated 31.07.2020 No. 258-FZ “On experimental legal regimes in the field of digital innovations in the Russian Federation”. Available at: https://base.garant.ru/74451176/?ysclid=mcujfao162823696623 (in Russ.) (accessed 23.06.2023).
16. Federal Law dated 21.11.2011 No. 323-FZ “On the fundamentals of health protection of citizens in the Russian Federation”. Available at: https://base.garant.ru/12191967/?ysclid=mcujitz7di937678356 (in Russ.) (accessed 23.06.2023).
17. Resolution of the Government of the RF dated 30.11.2024 No. 1684 “On approval of the rules for state registration of medical devices”. Available at: https://www.garant.ru/products/ipo/prime/doc/410924190/?ysclid=mcujo7ypgi543807069 (in Russ.) (accessed 23.06.2023).
18. Order of the Ministry of Health of the RF dated 6.06.2012 No. 4n “On approval of the nomenclature classification of medical devices”. Available at: https://base.garant.ru/70199586/ (in Russ.) (accessed 23.06.2023).
19. Code of ethics for the use of artificial intelligence in healthcare. Version 2.1 (approved by the Interdepartmental Working Group under the Ministry of Health of the Russian Federation on the creation, development and implementation in clinical practice of medical products and services using artificial intelligence technologies, protocol of February 14, 2025 No. 90/18-0/117). Available at: https://www.garant.ru/products/ipo/prime/doc/411615533/?ysclid=mcujwgpzg7498477087 (in Russ.) (accessed 23.06.2023).
20. Baltutite I.V. Legal problems of the use of artificial intelligence in healthcare. Legal Concept. 2022; 21 (2): 140–8 (in Russ.). https://doi.org/10.15688/lc.jvolsu.2022.2.18.
21. Caruana R., Lou Y., Gehrke J., et al. Intelligible models for healthcare: predicting pneumonia risk and hospital 30-day readmission. In: Proceedings of the 21st ACM SIGKDD International Conference on Knowledge Discovery and Data Mining. 2015: 1721–30. https://doi.org/10.1145/2783258.2788613.
22. Proposed regulatory framework for modifications to artificial intelligence/machine learning (AI/ML)-based software as a medical device (SaMD). Available at: https://www.fda.gov/media/122535/download (accessed 18.06.2025).
23. Esteva A., Kuprel B., Novoa R.A., et al. Dermatologist-level classification of skin cancer with deep neural networks. Nature. 2017; 542: 115–8. https://doi.org/10.1038/nature21056.
24. Ribeiro M.T., Singh S., Guestrin C. “Why should i trust you?”: explaining the predictions of any classifier. arXiv:1602.04938. https://doi.org/10.48550/arXiv.1602.04938.
25. International Medical Device Regulators ForumGood machine learning practice for medical device development: guiding principles. Available at: https://www.imdrf.org/documents/good-machine-learning-practice-medical-device-development-guiding-principles (accessed 21.06.2025).
26. Health insurance portability and accountability act. 1996 Available at: https://www.congress.gov/bill/104th-congress/house-bill/3103/text (accessed 18.06.2025).
27. Lyell D., Wang Y., Coiera E., Magrabi F. More than algorithms: an analysis of safety events involving ML-enabled medical devices reported to the FDA. J Am Med Inform Assoc. 2023; 30 (7): 1227–36. https://doi.org/10.1093/jamia/ocad065.
28. Froomkin M., Kerr I., Pineau J. When AIS outperform doctors: confronting the challenges of a Tort-Induced Over-Reliance on machine learning. Arizona Law Rev. 2019; 61: 33–99. http://doi.org/10.2139/ssrn.3114347.
29. Software as a medical device (SaMD). International Medical Device Regulators Forum. Available at: https://www.fda.gov/media/100714/download (accessed 19.06.2025).
30. Digital health software precertification (Pre-Cert) pilot program. Available at: https://www.fda.gov/medical-devices/digital-health-center-excellence/digital-health-software-precertification-pre-cert-pilot-program (accessed 19.06.2025).
31. Wachter S., Mittelstadt B., Floridi L. Why a right to explanation of automated decision-making does not exist in the general data protection regulation. SSRN Electronic Journal. 2016. http://doi.org/10.1093/idpl/ipx005.
Review
For citations:
Korabelnikov D.I., Lamotkin A.I. Artificial intelligence in healthcare: global implementation, legal regulation, problems and ethical issues. FARMAKOEKONOMIKA. Modern Pharmacoeconomics and Pharmacoepidemiology. (In Russ.) https://doi.org/10.17749/2070-4909/farmakoekonomika.2025.328
Views:
12
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Email this article 